These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28299319)

  • 1. Clinical Epidemiology of Mineral Bone Disorder Markers in Prevalent Hemodialysis Patients in the Xinjiang Uyghur Autonomous Region in China.
    Sun YP; Yang WJ; Li SH; Han YY; Liu J
    Biomed Res Int; 2017; 2017():2516934. PubMed ID: 28299319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral and bone disorder in hemodialysis patients in the Tibetan Plateau: a multicenter cross-sectional study.
    Dang ZH; Tang C; Li GL; Luobu C; Qing D; Ma ZH; Qu JF; Suolang L; Liu LJ
    Ren Fail; 2019 Nov; 41(1):636-643. PubMed ID: 31269846
    [No Abstract]   [Full Text] [Related]  

  • 3. Mineral and bone disorder in Chinese dialysis patients: a multicenter study.
    Kong X; Zhang L; Zhang L; Chen N; Gu Y; Yu X; Liu W; Chen J; Peng L; Yuan W; Wu H; Chen W; Fan M; He L; Ding F; Chen X; Xiong Z; Zhang J; Jia Q; Shi W; Xing C; Tang X; Hou F; Shu G; Mei C; Wang L; Xu D; Ni Z; Zuo L; Wang M; Wang H
    BMC Nephrol; 2012 Sep; 13():116. PubMed ID: 22994525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation on maintenance hemodialysis patients with mineral and bone disorder in Anhui province, China.
    Tao S; Li X; Liu Z; Bai Y; Qian G; Wu H; Li J; Guo Y; Yang S; Chen L; Yang J; Han J; Ma S; Yang J; Yu L; Shui R; Jin X; Wang H; Zhang F; Chen T; Li X; Zong X; Liu L; Fan J; Wang W; Zhang Y; Shi G; Wang D
    Int Urol Nephrol; 2023 Feb; 55(2):389-398. PubMed ID: 35951256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relation Between Variability of Intact Parathyroid Hormone, Calcium, and Cardiac Mortality in Hemodialysis Patients.
    Ulusoy S; Ozkan G; Guvercin B; Yavuz A
    Artif Organs; 2016 Nov; 40(11):1078-1085. PubMed ID: 27110947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines.
    Liu Y; Lee WC; Cheng BC; Li LC; Lee CH; Chang WX; Chen JB
    Biomed Res Int; 2016; 2016():1523124. PubMed ID: 28003998
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients.
    Soohoo M; Feng M; Obi Y; Streja E; Rhee CM; Lau WL; Wang J; Ravel VA; Brunelli S; Kovesdy CP; Kalantar-Zadeh K
    Am J Nephrol; 2016; 43(2):85-96. PubMed ID: 26950688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and consequences of mineral bone disorder in haemodialysis patients: lessons from The Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Blayney MJ; Tentori F
    J Ren Care; 2009 Mar; 35 Suppl 1():7-13. PubMed ID: 19222725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineral bone disorder and its management among hemodialysis patients in the Gulf Cooperation Council: Initial findings from the dialysis outcomes and practice patterns study (2012-2015).
    Al Salmi I; AlRukhaimi M; AlSahow A; Shaheen FA; Al-Ghamdi SM; AlAli F; AlGhareeb S; Al Maimani Y; AlGhonaim M; Bieber B; Tentori F; Pisoni RL;
    Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):62-80. PubMed ID: 27991480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineral and Bone Disorder and Its Association with Cardiovascular Parameters in Chinese Patients with Chronic Kidney Disease.
    Zhou C; Wang F; Wang JW; Zhang LX; Zhao MH
    Chin Med J (Engl); 2016 Oct; 129(19):2275-80. PubMed ID: 27647184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hemodialysis patients without marked elevation of intact parathyroid hormone are also good candidates for early intervention with cinacalcet.
    Nishida H; Masakane I; Kudo K; Ito M; Tanida H; Koshika M; Nishida W; Tomita Y
    Ther Apher Dial; 2013 Jun; 17(3):325-31. PubMed ID: 23735149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and pattern of renal osteodystrophy in chronic hemodialysis patients: a cross sectional study of 103 patients.
    Buargub MA; Nabulsi MF; Shafeh TA
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):401-7. PubMed ID: 16970264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
    Jean G; Daugas É; Roth H; Drueke T; Bouchet JL; Hannedouche T; London G; Fouque D
    Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
    Maduell F; Gorriz JL; Pallardo LM; Pons R; Santiago C;
    J Nephrol; 2005; 18(6):739-48. PubMed ID: 16358233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CKD-MBD Markers with All-Cause Mortality in Prevalent Hemodialysis Patients: A Cohort Study in Beijing.
    Li D; Zhang L; Zuo L; Jin CG; Li WG; Chen JB
    PLoS One; 2017; 12(1):e0168537. PubMed ID: 28045985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of chronic kidney disease-mineral bone disorders in newly detected advanced renal failure patients: A Hospital-based cross-sectional study.
    Etta PK; Sharma RK; Gupta A
    Saudi J Kidney Dis Transpl; 2017; 28(4):874-885. PubMed ID: 28748891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of prevalence, biochemical profile, and drugs associated with chronic kidney disease-mineral and bone disorder in 11 dialysis centers.
    Abrita RR; Pereira BDS; Fernandes NDS; Abrita R; Huaira RMNH; Bastos MG; Fernandes NMDS
    J Bras Nefrol; 2018; 40(1):26-34. PubMed ID: 29796575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influences of method of calcium correction and the timing of blood collection on application of the K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Japan.
    Yokoyama K; Katoh N; Kasai K; Kubo H; Murai S; Shoji R; Imamura N; Saika S; Yumita S; Ishida M; Takasu S; Kono T; Yoshida Y; Wakabayashi T; Kimua Y; Hosoya T
    Ther Apher Dial; 2006 Jun; 10(3):257-61. PubMed ID: 16817790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CKD-MBD phenotype on health-related quality of life in patients receiving maintenance hemodialysis: A cross-sectional study.
    Luo L; Chen Q
    J Int Med Res; 2020 Feb; 48(2):300060519895844. PubMed ID: 32054360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.